Infertility due to polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: Consume one omega-3 capsule (1000 mg, containing 180 mg EPA and 120 mg DHA from pourateb gostar drug company) daily for eight-week. Intervention 2: Control group: T
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Infertile women with polycystic ovarian syndrome (18 to 35 years old) who have not had a pregnancy after 12 months of unprotected intercourse
Exclusion criteria
Exclusion criteria: Unwillingness to participate in the study Drug allergy to letrozole, tamoxifen, estradiol, or omega-3 presence of any other pathology that has led to infertility in the patient or his partner. Liver or kidney dysfunction Diabetes mellitus (type one or two) Thyroid dysfunction Congenital adrenal hyperplasia Abnormal hysterosalpingography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate in infertile women with polycystic ovary syndrome. Timepoint: Measurement of the number and size of follicles will be performed via transvaginal ultrasound on days 3, 7, and 12 of the menstrual cycle. Method of measurement: trans vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy incidence. Timepoint: At least 14 days after ovulation. Method of measurement: Pregnancy diagnosis will be based on ultrasound and ß-HCG titer levels. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactathar rasekhjahromi
Jahrom University of Medical Sciences
Outcome results
None listed